Diagnostic products and applications of pulmonary hypertension based on biomarkers
A biomarker and product technology, applied in the field of biomedicine, can solve problems such as the difficulty of early PH diagnosis, achieve the effects of reducing disability and mortality, improving detection ability and efficiency, and delaying the progress of PH
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0064] Example 1 Detection of Biomarkers Related to Pulmonary Hypertension
[0065] 1. Sample collection
[0066] Collect blood samples from 7 patients with chronic thromboembolic pulmonary hypertension (CTEPH) and 5 healthy control groups, and record the basic information of the patients and healthy control groups in detail, including age, gender, BMI, etc., among which the disease group There was no statistical difference with the healthy group in age, gender, BMI, etc.
[0067] Disease group inclusion criteria: CTEPH was diagnosed by right heart catheterization, pulmonary ventilation perfusion scan or CT pulmonary angiography (CTPA). The diagnosis of CTEPH needs to meet the following three conditions at the same time: ① Effective anticoagulant therapy has been performed for at least 3 months to exclude subacute PTE; ② V / Q imaging scan shows at least one pulmonary segment perfusion defect, or multi-slice spiral CT pulmonary artery Imaging (computed tomography pul-monaryang...
Embodiment 2
[0107] Example 2 Verification of differential genes and detection of diagnostic efficacy
[0108] 1. Data and preprocessing
[0109] Download the gene expression data of pulmonary arterial hypertension and its control dataset GSE33463 from the GEO database, and use the annotation file to annotate it. The average value of multiple probes corresponding to the same gene is taken as its expression level, and then the gene expression matrix file is obtained.
[0110] 2. Differential expression analysis
[0111] Expression analysis of differential genes was performed using the "limma" package in R software.
[0112] The analysis results showed that the expressions of PVALB and KCNA5 were significantly up-regulated in patients with pulmonary arterial hypertension, and the expression of SPNS3 was significantly down-regulated in patients with pulmonary arterial hypertension. Figure 1-3 As shown, among them, *: P<0.05; **: P<0.01; ***: P<0.001.
[0113] 3. Analysis of diagnostic eff...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



